Is ACAD or RGC more profitable?

ACAD runs the higher net margin — ACAD at 33.42% versus RGC at 0.00%.

How have ACAD and RGC total returns compared?

Over the past 5 years, ACAD delivered 3.52% and RGC delivered 67.94% annualized total return. Past performance doesn't predict future results.

Acadia Pharmaceuticals Inc. (ACAD) vs Regencell Bioscience Holdings Limited (RGC)

A side-by-side comparison of Acadia Pharmaceuticals Inc. and Regencell Bioscience Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ACAD

Acadia Pharmaceuticals Inc.

$3.39B

$19.78HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT

RGC

Regencell Bioscience Holdings Limited

$3.64B

$7.34HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

Total return — ACAD vs RGC

growth of $100 · dividends reinvested · last 5y

ACAD -15.2% (-3.2%/yr)RGC +2520.2% (+92.2%/yr)RGC compounded faster over this window

Log scale — wide-divergence pair

ACAD RGC

ACAD vs RGC: by the numbers

•RGC is the larger company ($3.64B vs $3.39B market cap).
•ACAD is profitable (33.42% net margin) while RGC runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	ACAD	RGC
P/E ratio	8.91	N/A
Forward P/E	32.10	N/A
P/S ratio	2.97	N/A
P/B ratio	2.59	2982.47
EV / EBITDA	31.25	N/A
FCF yield	5.15%	N/A

Profitability

Metric	ACAD	RGC
Gross margin	91.13%	0.00%
Operating margin	7.59%	0.00%
Net margin	33.42%	0.00%
ROE	29.12%	-73.75%
ROIC	6.25%	-69.75%

Growth (annualized)

Metric	ACAD	RGC
Revenue CAGR (5Y)	19.70%	N/A
Total return CAGR (5Y)	3.52%	67.94%

Frequently asked

Is ACAD or RGC more profitable?: ACAD runs the higher net margin — ACAD at 33.42% versus RGC at 0.00%.
How have ACAD and RGC total returns compared?: Over the past 5 years, ACAD delivered 3.52% and RGC delivered 67.94% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ACAD analysis Full RGC analysis Interactive comparison tool

Dig into the metrics

Acadia Pharmaceuticals P/E ratio Acadia Pharmaceuticals ROE Regencell Bioscience ROE Acadia Pharmaceuticals operating margin Regencell Bioscience operating margin Acadia Pharmaceuticals revenue growth Regencell Bioscience revenue growth Acadia Pharmaceuticals free cash flow Regencell Bioscience free cash flow

Acadia Pharmaceuticals & Regencell Bioscience appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.